1. Home
  2. Stock quotes
  3. Milestone Pharmaceuticals
  4. Financial Statements
  5. Income Statement
Milestone Pharmaceuticals logo
Milestone Pharmaceuticals MIST
$ 1.84 -1.08%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Milestone Pharmaceuticals Income Statement 2011-2024 | MIST

Annual Income Statement Milestone Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

 52.2 M 120 M 207 M 116 M 347 M - - - - - - - -

Shares

 33.5 M 34.3 M 29.9 M 15.8 M 15.8 M - - - - - - - -

Historical Prices

 1.56 3.51 6.94 7.38 22.1 - - - - - - - -

Net Income

 -59.7 M -58.4 M -42.9 M -50 M -55.2 M -23.2 M -8.09 M - - - - - -

Revenue

 - - - - - - - - - - - - -

Cost of Revenue

 - - - - - - - - - - - - -

Gross Profit

 - - - - - - - - - - - - -

Operating Income

 -61.1 M -59.6 M -43.1 M -50.7 M -57.9 M -23.8 M - - - - - - -

Interest Expense

 2.55 M - - - - - - - - - - - -

EBITDA

 -61 M -59.6 M -43 M -50.6 M -57.8 M -23.8 M -8.26 M - - - - - -

Operating Expenses

 - - - 50.7 M 57.9 M - - - - - - - -

General and Administrative Expenses

 15.9 M 15.7 M 12.4 M 10.3 M 7 M 3.05 M 1.5 M - - - - - -

All numbers in USD currency

Quarterly Income Statement Milestone Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

 53.3 M 53.3 M 53.2 M 33.5 M 33.5 M 33.4 M 33.3 M 34.3 M 30.4 M 30 M 29.9 M 29.9 M 29.9 M 29.8 M 41.3 M 29.8 M 29.8 M 24.6 M 24.5 M 24.5 M 24.5 M 13.2 M 603 K 597 K 283 K 282 K 269 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

 -9.44 M -9.36 M -10.4 M - -15.1 M -16 M -15 M - -14.6 M -16.6 M -14 M - -14.2 M 770 K -12.5 M - -12 M -13 M -16.3 M - -12.8 M -13.7 M -10.5 M - -5.7 M -3.59 M -4.18 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

 -9.62 M -9.66 M -10.5 M - -15.4 M -16.4 M -15.5 M - -15 M -16.8 M -14 M - -14.3 M 712 K -12.6 M - -12.1 M -13.1 M -16.8 M - -13.7 M -14.3 M -10.9 M - -5.78 M -3.68 M -4.26 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

 - - 872 K - 841 K 820 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

 - - -10.4 M - - - -15.5 M - -15 M -16.8 M -14 M - -14.2 M 758 K -12.6 M - -12 M -13.1 M -16.7 M - -13.7 M -14.3 M -10.9 M - -5.78 M -3.67 M -4.25 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

 3.74 M 5.05 M 3.95 M - 4.23 M 4.44 M 3.89 M - 4.03 M 3.92 M 3.64 M - 2.96 M 3.02 M 2.63 M - 2.95 M 2.96 M 2.7 M - 2.1 M 1.64 M 979 K - 646 K 750 K 439 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency